Protection against myocardial ischemia-reperfusion injury in clinical practice;Protección contra el daño miocárdico por isquemia-reperfusión en la práctica clínica

Revista Espanola de Cardiologia

Volumn 67, Issue 5, 2014, Pages 394-404

  Garcia Dorado, David ^a   Rodríguez Sinovas, Antonio ^a   Ruiz Meana, Marisol ^a   Inserte, Javier ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Myocardial infarction; Protein kinase G; Remote ischemic conditioning; Reperfusion injury

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALPAIN; CYCLIC GMP; CYCLOSPORIN; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; INSULIN;

AGE; ARTICLE; CELL DEATH; CELL PH; CLINICAL PRACTICE; COMORBIDITY; CORONARY ARTERY OCCLUSION; ENZYME ACTIVATION; GENDER; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; ISCHEMIC POSTCONDITIONING; MITOCHONDRION; OXIDATIVE STRESS; QUALITY OF LIFE; REPERFUSION INJURY; SARCOPLASMIC RETICULUM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL; ADVERSE EFFECTS; CLINICAL TRIAL (TOPIC); COMPLICATION; HEART MUSCLE REPERFUSION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY;

CLINICAL TRIALS AS TOPIC; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY;

EID: 84899625540     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2014.01.011     Document Type: Article

References (150)

1. C.D. Mathers, and D. Loncar Projections of global mortality and burden of disease from 2002 to 2030 PLoS Med 3 2006 e442
2. H.N. Sabbah, and S. Goldstein Ventricular remodelling: consequences and therapy Eur Heart J 14 (suppl C) 1993 24 29
3. J.J. Gajarsa, and R.A. Kloner Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities Heart Fail Rev 16 2011 13 21
4. P. Gaudron, C. Eilles, I. Kugler, and G. Ertl Progressive left ventricular dysfunction and remodeling after myocardial infarction Potential mechanisms and early predictors Circulation 87 1993 755 763
5. J.N. Cohn, R. Ferrari, and N. Sharpe Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling Behalf of an International Forum on Cardiac Remodeling J Am Coll Cardiol 35 2000 569 582
6. V. Fuster, P.R. Moreno, Z.A. Fayad, R. Corti, and J.J. Badimon Atherothrombosis and high-risk plaque: part I: evolving concepts J Am Coll Cardiol 46 2005 937 954
7. S.C. Smith Jr. Current and future directions of cardiovascular risk prediction Am J Cardiol 97 2006 28A 32A
8. B.M. Scirica Acute coronary syndrome: emerging tools for diagnosis and risk assessment J Am Coll Cardiol 55 2010 1403 1415
9. S.B. Quelly, and L.S. Lieberman Global prevalence of overweight and obesity in preschoolers Anthropol Anz 68 2011 437 456
10. M. Franco, B. Sanz, L. Otero, A. Dominguez-Vila, and B. Caballero Prevention of childhood obesity in Spain: a focus on policies outside the health sector SESPAS report 2010 Gac Sanit 24 Suppl 1 2010 49 55
11. J.G. Canto, C.I. Kiefe, W.J. Rogers, E.D. Peterson, P.D. Frederick, and W.J. French et al. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction JAMA 306 2011 2120 2127
12. J.G. Canto, C.I. Kiefe, W.J. Rogers, E.D. Peterson, P.D. Frederick, and W.J. French et al. Atherosclerotic risk factors and their association with hospital mortality among patients with first myocardial infarction (from the National Registry of Myocardial Infarction) Am J Cardiol 110 2012 1256 1261
13. P.L. Thompson, E.E. Fletcher, and V. Katavatis Enzymatic indices of myocardial necrosis: influence on short- and long-term prognosis after myocardial infarction Circulation 59 1979 113 119
14. K.A. Reimer, J.E. Lowe, M.M. Rasmussen, and R.B. Jennings The wavefront phenomenon of ischemic cell death 1. Myocardial infarct size vs duration of coronary occlusion in dogs Circulation 56 1977 786 794
15. D. Garcia-Dorado, and B. Garcia del Blanco Door-to-balloon time and mortality N Engl J Med 370 2014 179
16. J.M. Downey, and M.V. Cohen Reducing infarct size in the setting of acute myocardial infarction Prog Cardiovasc Dis 48 2006 363 371
17. K. Goel, D.S. Pinto, and C.M. Gibson Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: a systematic review Am Heart J 165 2013 451 467
18. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Intravenous streptokinase given within 0-4 hours of onset of myocardial infarction reduced mortality in ISIS-2 Lancet 1 1987 502
19. position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology D.J. Hausenloy, H.S. Bøtker, G. Condorelli, P. Ferdinandy, D. Garcia-Dorado, and G. Heusch et al. Translating cardioprotection for patient benefit Cardiovasc Res. 98 2013 7 27
20. G. Takemura, M. Nakagawa, H. Kanamori, S. Minatoguchi, and H. Fujiwara Benefits of reperfusion beyond infarct size limitation Cardiovasc Res 83 2009 269 276
21. R. Tennant, and C.J. Wiggers The effect of coronary occlusion on myocardial contraction Am J Physiol 112 1935 351 361
22. M. Majidi, A.S. Kosinski, S.M. Al Khatib, M.E. Lemmert, L. Smolders, and A. Van Weert et al. Reperfusion ventricular arrhythmia 'bursts' in TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction: a more precise definition of reperfusion arrhythmias Europace 10 2008 988 997
23. T.W. Lang, E. Corday, H. Gold, S. Meerbaum, S. Rubins, and C. Costantini et al. Consequences of reperfusion after coronary occlusion Effects on hemody-namic and regional myocardial metabolic function Am J Cardiol 33 1974 69 81
24. K. Sakai, M.M. Gebhard, P.G. Spieckermann, and H.J. Bretschneider Enzyme release resulting from total ischemia and reperfusion in the isolated, perfused guinea pig heart J Mol Cell Cardiol 7 1975 827 840
25. G. Heusch, and R. Schulz Characterization of hibernating and stunned myocardium Eur Heart J 18 18 Suppl D 1997 D102 D110
26. H.M. Piper, D. Garcia-Dorado, and M. Ovize A fresh look at reperfusion injury Cardiovasc Res 38 1998 291 300
27. D. Garcia-Dorado, H.M. Piper, and Postconditioning: reperfusion of «reperfusion injury» after hibernation Cardiovasc Res 69 2006 1 3
28. P.O. Sjoquist, G. Duker, and O. Almgren Distribution of the collateral blood flow at the lateral border of the ischemic myocardium after acute coronary occlusion in the pig and the dog Basic Res Cardiol 79 1984 164 175
29. C. Berry, K.P. Balachandran, P.L. L'Allier, J. Lesperance, R. Bonan, and K.G. Oldroyd Importance of collateral circulation in coronary heart disease Eur Heart J 28 2007 278 291
30. D. Garcia-Dorado, M. Andres-Villarreal, M. Ruiz-Meana, J. Inserte, and I. Barba Myocardial edema: a translational view J Mol Cell Cardiol 52 2012 931 939
31. D. Sanchis, M. Llovera, M. Ballester, and J.X. Comella An alternative view of apoptosis in heart development and disease Cardiovasc Res 77 2008 448 451
32. B.G. Schwartz, and R.A. Kloner Coronary no reflow J Mol Cell Cardiol 52 2012 873 882
33. J.A. Barrabes, D. Garcia-Dorado, M.A. Gonzalez, M. Ruiz-Meana, J. Solares, and Y. Puigfel et al. Regional expansion during myocardial ischemia predicts ventricular fibrillation and coronary reocclusion Am J Physiol 274 1998 H1767 H1775
34. T. Reffelmann, S.L. Hale, J.S. Dow, and R.A. Kloner No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion Circulation 108 2003 2911 2917
35. D. Garcia-Dorado Myocardial reperfusion injury: a new view Cardiovasc Res 61 2004 363 364
36. D. Garcia-Dorado, M. Ruiz-Meana, and H.M. Piper Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues Cardiovasc Res 83 2009 165 168
37. H.M. Piper, K. Meuter, and C. Schafer Cellular mechanisms of ischemia-reperfusion injury Ann Thorac Surg 75 2003 S644 S648
38. H.M. Piper, Y. Abdallah, and C. Schafer The first minutes of reperfusion: a window of opportunity for cardioprotection Cardiovasc Res 61 2004 365 371
39. M. Hendrikx, K. Mubagwa, F. Verdonck, K. Overloop, P. Van Hecke, and F. Vanstapel et al. New Na(+)-H + exchange inhibitor HOE 694 improves postischemic function and high-energy phosphate resynthesis and reduces Ca2 + overload in isolated perfused rabbit heart Circulation 89 1994 2787 2798
40. J. Inserte, I. Barba, V. Hernando, and D. Garcia-Dorado Delayed recovery of intracel-lular acidosis during reperfusion prevents calpain activation and determines protection in postconditioned myocardium Cardiovasc Res 81 2009 116 122
41. K.C. Bowers, A.P. Allshire, and P.H. Cobbold Bioluminescent measurement in single cardiomyocytes of sudden cytosolic ATP depletion coincident with rigor J Mol Cell Cardiol 24 1992 213 218
42. G.J. Grover, K.S. Atwal, P.G. Sleph, F.L. Wang, H. Monshizadegan, and T. Monticello A.T.P. Excessive hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity Am J Physiol Heart Circ Physiol 287 2004 H1747 H1755
43. M. Ruiz-Meana, D. Garcia-Dorado, E. Miro-Casas, A. Abellan, and J. Soler-Soler Mitochondrial Ca2 + uptake during simulated ischemia does not affect permeability transition pore opening upon simulated reperfusion Cardiovasc Res 71 2006 715 724
44. H.M. Piper, S. Kasseckert, and Y. Abdallah The sarcoplasmic reticulum as the primary target of reperfusion protection Cardiovasc Res 70 2006 170 173
45. H.M. Piper, Y. Abdallah, S. Kasseckert, and K.D. Schluter Sarcoplasmic reticulum-mitochondrial interaction in the mechanism of acute reperfusion injury Viewpoint Cardiovasc Res 77 2008 234 236
46. E.G. Kranias, and R.J. Hajjar Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome Circ Res 110 2012 1646 1660
47. M.L. Joiner, O.M. Koval, J. Li, B.J. He, C. Allamargot, and Z. Gao et al. CaMKII determines mitochondrial stress responses in heart Nature 491 2012 269 273
48. M. Ruiz-Meana, D. Garcia-Dorado, M.A. Gonzalez, J.A. Barrabes, and J. Soler-Soler Effect of osmotic stress on sarcolemmal integrity of isolated cardiomyocytes following transient metabolic inhibition Cardiovasc Res 30 1995 64 69
49. J.A. Barrabes, D. Garcia-Dorado, M. Ruiz-Meana, H.M. Piper, J. Solares, and M.A. Gonzalez et al. Myocardial segment shrinkage during coronary reperfusion in situ Relation to hypercontracture and myocardial necrosis Pflugers Arch 431 1996 519 526
50. S.G. Priori, M. Mantica, C. Napolitano, and P.J. Schwartz Early afterdepolarizations induced in vivo by reperfusion of ischemic myocardium. A possible mechanism for reperfusion arrhythmias Circulation 81 1990 1911 1920
51. A.P. Halestrap What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 46 2009 821 831
52. Y. Abdallah, S.A. Kasseckert, W. Iraqi, M. Said, T. Shahzad, and A. Erdogan et al. Interplay between Ca2 + cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes J Cell Mol Med 15 2011 2478 2485
53. M. Ruiz-Meana, A. Abellan, E. Miro-Casas, and D. Garcia-Dorado Opening of mitochondrial permeability transition pore induces hypercontracture in Ca(2 +) overloaded cardiac myocytes Basic Res Cardiol 102 2007 542 552
54. M. Ruiz-Meana, J. Inserte, C. Fernandez-Sanz, V. Hernando, E. Miro-Casas, and I. Barba et al. The role of mitochondrial permeability transition in reperfusion-induced cardiomyocyte death depends on the duration of ischemia Basic Res Cardiol 106 2011 1259 1268
55. M. Ruiz-Meana, P. Pina, D. Garcia-Dorado, A. Rodriguez-Sinovas, I. Barba, and E. Miro-Casas et al. Glycine protects cardiomyocytes against lethal reoxygenation injury by inhibiting mitochondrial permeability transition J Physiol 558 2004 873 882
56. E.J. Griffiths, and A.P. Halestrap Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion Biochem J 307 1995 93 98
57. J. Inserte, D. Garcia-Dorado, M. Ruiz-Meana, L. Agullo, P. Pina, and J. Soler-Soler Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism Cardiovasc Res 64 2004 105 114
58. J. Inserte, D. Garcia-Dorado, V. Hernando, and J. Soler-Soler Calpain-mediated impairment of Na +/K +-ATPase activity during early reperfusion contributes to cell death after myocardial ischemia Circ Res 97 2005 465 473
59. V. Hernando, J. Inserte, C.L. Sartorio, V.M. Parra, M. Poncelas-Nozal, and D. Garcia-Dorado Calpain translocation and activation as pharmacological targets during myocardial ischemia/reperfusion J Mol Cell Cardiol 49 2010 271 279
60. A.P. Halestrap, S.J. Clarke, and S.A. Javadov Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection Cardiovasc Res 61 2004 372 385
61. J.R. Erickson, B.J. He, I.M. Grumbach, and M.E. Anderson CaMKII in the cardiovascular system: sensing redox states Physiol Rev 91 2011 889 915
62. J. Inserte, V. Hernando, U. Vilardosa, E. Abad, M. Poncelas-Nozal, and D. Garcia-Dorado Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling J Am Heart Assoc 2 2013 e005975
63. A. Rodriguez-Sinovas, J.A. Sanchez, A. Gonzalez-Loyola, I. Barba, M. Morente, and R. Aguilar et al. Effects of substitution of Cx43 by Cx32 on myocardial energy metabolism, tolerance to ischemia and preconditioning protection J Physiol 588 2010 1139 1151
64. J.A. Sanchez, A. Rodriguez-Sinovas, I. Barba, E. Miro-Casas, C. Fernandez-Sanz, and M. Ruiz-Meana et al. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection Basic Res Cardiol 108 2013 351
65. A. Rodriguez-Sinovas, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium J Physiol 559 2004 245 257
66. D. Garcia-Dorado, A. Rodriguez-Sinovas, and M. Ruiz-Meana Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion Cardiovasc Res 61 2004 386 401
67. M. Ruiz-Meana, D. Garcia-Dorado, B. Hofstaetter, H.M. Piper, and J. Soler-Soler Propagation of cardiomyocyte hypercontracture by passage of Na(+) through gap junctions Circ Res 85 1999 280 287
68. S. Liu, S. Taffet, L. Stoner, M. Delmar, M.L. Vallano, and J. Jalife A structural basis for the unequal sensitivity of the major cardiac and liver gap junctions to intracellular acidification: the carboxyl tail length Biophys J 64 1993 1422 1433
69. J.A. Barrabes, D. Garcia-Dorado, M. Mirabet, J. Inserte, L. Agullo, and B. Soriano et al. Antagonism of selectin function attenuates microvascular platelet deposition and platelet-mediated myocardial injury after transient ischemia J Am Coll Cardiol 45 2005 293 299
70. 12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts Thromb Haemost 104 2010 128 135
71. M. Mirabet, D. Garcia-Dorado, J. Inserte, J.A. Barrabes, R.M. Lidon, and B. Soriano et al. Platelets activated by transient coronary occlusion exacerbate ischemia-reperfusion injury in rat hearts Am J Physiol Heart Circ Physiol 283 2002 H1134 H1141
72. M. Mirabet, D. Garcia-Dorado, M. Ruiz-Meana, J.A. Barrabes, and J. Soler-Soler Thrombin increases cardiomyocyte acute cell death after ischemia and reperfusion J Mol Cell Cardiol 39 2005 277 283
73. S. Simsekyilmaz, H.A. Cabrera-Fuentes, S. Meiler, S. Kostin, Y. Baumer, and E.A. Liehn et al. Role of extracellular RNA in atherosclerotic plaque formation in mice Circulation 129 2014 598 606
74. J. Inserte, J.A. Barrabes, V. Hernando, and D. Garcia-Dorado Orphan targets for reperfusion injury Cardiovasc Res 83 2009 169 178
75. P. Staat, G. Rioufol, C. Piot, Y. Cottin, T.T. Cung, and I. L'Huillier et al. Postconditioning the human heart Circulation 112 2005 2143 2148
76. F. Thuny, O. Lairez, F. Roubille, N. Mewton, G. Rioufol, and C. Sportouch et al. Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol 59 2012 2175 2181
77. Z.Q. Zhao, J.S. Corvera, M.E. Halkos, F. Kerendi, N.P. Wang, and R.A. Guyton et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol Heart Circ Physiol 285 2003 H579 H588
78. A. Rodriguez-Sinovas, A. Cabestrero, D.B. Garcia, J. Inserte, A. Garcia, and D. Garcia-Dorado Intracoronary acid infusion as an alternative to ischemic postconditioning in pigs Basic Res Cardiol 104 2009 761 771
79. J. Inserte, M. Ruiz-Meana, A. Rodriguez-Sinovas, I. Barba, and D. Garcia-Dorado Contribution of delayed intracellular pH recovery to ischemic postconditioning protection Antioxid Redox Signal 14 2011 923 939
80. J. Inserte, I. Barba, M. Poncelas-Nozal, V. Hernando, L. Agullo, and M. Ruiz-Meana et al. cGMP/PKG pathway mediates myocardial postconditioning protection in rat hearts by delaying normalization of intracellular acidosis during reperfusion J Mol Cell Cardiol 50 2011 903 909
81. G. Andreka, M. Vertesaljai, G. Szantho, G. Font, Z. Piroth, and G. Fontos et al. Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs Heart 93 2007 749 752
82. M.R. Schmidt, M. Smerup, I.E. Konstantinov, M. Shimizu, J. Li, and M. Cheung et al. Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning Am J Physiol Heart Circ Physiol 292 2007 H1883 H1890
83. D.J. Hausenloy, E.K. Iliodromitis, I. Andreadou, A. Papalois, G. Gritsopoulos, and M. Anastasiou-Nana et al. Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heart Cardiovasc Drugs Ther 26 2012 87 93
84. W. Shi, and J. Vinten-Johansen Endogenous cardioprotection by ischaemic postconditioning and remote conditioning Cardiovasc Res 94 2012 206 216
85. M.V. Cohen, and J.M. Downey Ischemic postconditioning: from receptor to end-effector Antioxid Redox Signal 14 2011 821 831
86. F. Padilla, D. Garcia-Dorado, L. Agullo, J.A. Barrabes, J. Inserte, and N. Escalona et al. Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs Cardiovasc Res 51 2001 592 600
87. J.S. Bice, Y. Keim, J.P. Stasch, and G.F. Baxter NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size Cardiovasc Res 101 2014 220 228
88. P. Ferdinandy, and R. Schulz Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning Br J Pharmacol 138 2003 532 543
89. A. Skyschally, R. Schulz, G. Heusch, and A. Cyclosporine at reperfusion reduces infarct size in pigs Cardiovasc Drugs Ther 24 2010 85 87
90. C.P. Baines, R.A. Kaiser, N.H. Purcell, N.S. Blair, H. Osinska, and M.A. Hambleton et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death Nature 434 2005 658 662
91. Y. Abdallah, A. Gkatzoflia, D. Gligorievski, S. Kasseckert, G. Euler, and K.D. Schluter et al. Insulin protects cardiomyocytes against reoxygenation-induced hypercontracture by a survival pathway targeting SR Ca2 + storage Cardiovasc Res 70 2006 346 353
92. A.K. Jonassen, E. Aasum, R.A. Riemersma, O.D. Mjos, and T.S. Larsen Glucose-insulin-potassium reduces infarct size when administered during reperfusion Cardiovasc Drugs Ther 14 2000 615 623
93. A.K. Jonassen, M.N. Sack, O.D. Mjos, and D.M. Yellon Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling Circ Res 89 2001 1191 1198
94. S. Ravassa, A. Zudaire, and J. Diez GLP-1 and cardioprotection: from bench to bedside Cardiovasc Res 94 2012 316 323
95. M. Khan, S. Meduru, M. Mostafa, S. Khan, K. Hideg, and P. Kuppusamy Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling J Pharmacol Exp Ther 333 2010 421 429
96. R. Rodrigo, J.C. Prieto, and R. Castillo Cardioprotection against ischaemia/reperfusion by vitamins C and E plus n-3 fatty acids: molecular mechanisms and potential clinical applications Clin Sci (Lond) 124 2013 1 15
97. M.T. Dirksen, G.J. Laarman, M.L. Simoons, and D.J. Duncker Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies Cardiovasc Res 74 2007 343 355
98. P.Z. Gerczuk, and R.A. Kloner An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials J Am Coll Cardiol 59 2012 969 978
99. D.J. Hausenloy, and D.M. Yellon Myocardial ischemia-reperfusion injury: a neglected therapeutic target J Clin Invest 123 2013 92 100
100. A. Rodriguez-Sinovas, Y. Abdallah, H.M. Piper, and D. Garcia-Dorado Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction Heart Fail Rev 12 2007 207 216
101. G. Heusch, and Cardioprotection: chances and challenges of its translation to the clinic Lancet 381 2013 166 175
102. C.E. Darling, P.B. Solari, C.S. Smith, M.I. Furman, and K. Przyklenk 'Postconditioning' the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection Basic Res Cardiol 102 2007 274 278
103. X. Freixa, N. Bellera, J.T. Ortiz-Perez, M. Jimenez, C. Pare, and X. Bosch et al. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention Eur Heart J 33 2012 103 112
104. M. Elzbieciak, K. Wita, M. Grabka, J. Chmurawa, A. Doruchowska, and M. Turski et al. Effect of postconditioning on infarction size, adverse left ventricular remodeling, and improvement in left ventricular systolic function in patients with first anterior STsegment elevation myocardial infarction Pol Arch Med Wewn 123 2013 268 276
105. X.C. Yang, Y. Liu, L.F. Wang, L. Cui, T. Wang, and Y.G. Ge et al. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention J Invasive Cardiol 19 2007 424 430
106. N. Mewton, F. Ivanès, M. Cour, and M. Ovize Postconditioning: from experimental proof to clinical concept Dis Model Mech 3 2010 39 44
107. A.E. Arai Magnetic resonance imaging for area at risk, myocardial infarction, and myocardial salvage J Cardiovasc Pharmacol Ther 16 2011 313 320
108. H.E. Botker, R. Kharbanda, M.R. Schmidt, M. Bottcher, A.K. Kaltoft, and C.J. Terkelsen et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial Lancet 375 2010 727 734
109. L. Candilio, A. Malik, and D.J. Hausenloy Protection of organs other than the heart by remote ischemic conditioning J Cardiovasc Med (Hagerstown) 14 2013 193 205
110. H. Zhong, Z. Gao, M. Chen, J. Zhao, F. Wang, and L. Li et al. Cardioprotective effect of remote ischemic postconditioning on children undergoing cardiac surgery: a randomized controlled trial Paediatr Anaesth 23 2013 726 733
111. M.M. Cheung, R.K. Kharbanda, I.E. Konstantinov, M. Shimizu, H. Frndova, and J. Li et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans J Am Coll Cardiol 47 2006 2277 2282
112. D.J. Hausenloy, P.K. Mwamure, V. Venugopal, J. Harris, M. Barnard, and E. Grundy et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial Lancet 370 2007 575 579
113. K. Munk, N.H. Andersen, M.R. Schmidt, S.S. Nielsen, C.J. Terkelsen, and E. Sloth et al. Remote ischemic conditioning in patients with myocardial infarction treated with primary angioplasty: impact on left ventricular function assessed by comprehensive echocardiography and gated single-photon emission CT Circ Cardiovasc Imaging 3 2010 656 662
114. I.A. Rahman, and J.G. Mascaro Steeds RP, Frenneaux MP, Nightingale P Gosling P, et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment? Circulation 122 2010 S53 S59
115. M. Kitakaze, M. Asakura, J. Kim, Y. Shintani, H. Asanuma, and T. Hamasaki et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials Lancet 370 2007 1483 1493
116. H. Thibault, C. Piot, P. Staat, L. Bontemps, C. Sportouch, and G. Rioufol et al. Long-term benefit of postconditioning Circulation 117 2008 1037 1044
117. H.P. Selker, J.R. Beshansky, P.R. Sheehan, J.M. Massaro, J.L. Griffith, and R.B. D'Agostino et al. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial JAMA 307 2012 1925 1933
118. J. Lonborg, H. Kelbaek, N. Vejlstrup, H.E. Botker, W.Y. Kim, and L. Holmvang et al. Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia Circ Cardiovasc Interv 5 2012 288 295
119. C. Piot, P. Croisille, P. Staat, H. Thibault, G. Rioufol, and N. Mewton et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction N Engl J Med 359 2008 473 481
120. F. Gao, E. Gao, T.L. Yue, E.H. Ohlstein, B.L. Lopez, and T.A. Christopher et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase Akt, and endothelial nitric oxide synthase phosphorylation Circulation 105 2002 1497 1502
121. L.H. Opie, K. Bruyneel, and P. Owen Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon Circulation 52 1975 49 57
122. A. Oates, R. Nubani, J. Smiley, L. Kistler, S. Hughey, and P. Theiss et al. Myocardial protection of insulin and potassium in a porcine ischemia-reperfusion model Surgery 146 2009 23 30
123. I.W. Suranadi, L. Demaison, V. Chate, S. Peltier, M. Richardson, and X. Leverve An increase in the redox state during reperfusion contributes to the cardioprotective effect of GIK solution J Appl Physiol 113 2012 775 784
124. R. Diaz, E.A. Paolasso, L.S. Piegas, C.D. Tajer, M.G. Moreno, R. Corvalán ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group Metabolic Modulation of Acute Myocardial Infarction. The ECLA Glucose-Insulin-Potassium Pilot Trial Circulation. 98 1998 2227 2234
125. L. Ceremuzynski, A. Budaj, A. Czepiel, T. Burzykowski, P. Achremczyk, and W. Smielak-Korombel et al. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial Cardiovasc Drugs Ther 13 1999 191 200
126. S.R. Mehta, S. Yusuf, R. Diaz, J. Zhu, P. Pais, and D. Xavier et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial JAMA 293 2005 437 446
127. L. Timmers, J.P. Henriques, D.P. De Kleijn, J.H. Devries, H. Kemperman, and P. Steendijk et al. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury J Am Coll Cardiol 53 2009 501 510
128. K. Ban, M.H. Noyan-Ashraf, J. Hoefer, S.S. Bolz, D.J. Drucker, and M. Husain Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways Circulation 117 2008 2340 2350
129. J.R. Timmer, I.C. Van der Horst, J.P. Ottervanger, G. De Luca, A.W. Van't Hof, and H.J. Bilo et al. Glucose-insulin-potassium infusion as adjunctive therapy in myocardial infarction: current evidence and potential mechanisms Ital Heart J 5 2004 727 731
130. J. Lonborg, N. Vejlstrup, H. Kelbaek, H.E. Botker, W.Y. Kim, and A.B. Mathiasen et al. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction Eur Heart J 33 2012 1491 1499
131. K.W. Mahaffey, J.A. Puma, N.A. Barbagelata, M.F. DiCarli, M.A. Leesar, and K.F. Browne et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial J Am Coll Cardiol 34 1999 1711 1720
132. A.M. Ross, R.J. Gibbons, G.W. Stone, R.A. Kloner, and R.W. Alexander A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II) J Am Coll Cardiol 45 2005 1775 1780
133. C.H. Lee, A. Low, B.C. Tai, M. Co, M.Y. Chan, and J. Lim et al. Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study Eur Heart J 28 2007 19 25
134. D. Garcia-Dorado, I. Otaegui, J.F. Rodríguez Palomares, E. Evangelista, V. Pineda, and R. Ruiz Salmerón et al. Primary results of the PROMISE trial: myocardial protection with intracoronary adenosine given before reperfusion in patients with STEMI Eur Heart J 34 Suppl 1 2014 669
135. S. Ghaffari, B. Kazemi, M. Toluey, and N. Sepehrvand The effect of prethrombolytic cyclosporine-A injection on clinical outcome of acute anterior ST-elevation myocardial infarction Cardiovasc Ther 31 2013 e34 e39
136. MITOCARE Study Group Rationale and design of the MITOCARE Study: a phase II, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of TRO40303 for the reduction of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction Cardiology 123 2012 201 207
137. B. Ibanez, S. Prat-Gonzalez, W.S. Speidl, G. Vilahur, A. Pinero, and G. Cimmino et al. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance Circulation 115 2007 2909 2916
138. B. Ibanez, C. Macaya, V. Sánchez-Brunete, G. Pizarro, L. Fernández-Friera, and A. Mateos et al. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial Circulation 128 2013 1495 1503
139. G. Ndrepepa, and A. Kastrati Intravenous beta-blockers in primary percutaneous coronary intervention: new hope for an old therapy Circulation 128 2013 1487 1489
140. H.H. Klein, S. Pich, R.M. Bohle, S. Lindert-Heimberg, and K. Nebendahl Na(+)/H(+) exchange inhibitor cariporide attenuates cell injury predominantly during ischemia and not at onset of reperfusion in porcine hearts with low residual blood flow Circulation 102 2000 1977 1982
141. A. Rodríguéz-Sinovas, D. García-Dorado, F. Padilla, J. Inserte, J.A. Barrabés, and M. Ruiz-Meana et al. Pre-treatment with the Na+/H+ exchange inhibitor cariporide delays cell-to-cell electrical uncoupling during myocardial ischemia Cardiovasc Res 58 2003 109 117
142. M. Ruiz-Meana, D. Garcia-Dorado, P. Pina, J. Inserte, L. Agullo, and J. Soler-Soler Cariporide preserves mitochondrial proton gradient and delays ATP depletion in cardiomyocytes during ischemic conditions Am J Physiol Heart Circ Physiol 285 2003 H999 H1006
143. P. Théroux, B.R. Chaitman, N. Danchin, L. Erhardt, T. Meinertz, and J.S. Schroeder et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators Circulation 102 2000 3032 3038
144. A.J. Ludman, D.M. Yellon, J. Hasleton, C. Ariti, G.G. Babu, and E. Boston-Griffiths et al. Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial Heart 97 2011 1560 1565
145. T. Cyrus, S.J. Mathews, and J.M. Lasala Use of mechanical assist during high-risk PCI and STEMI with cardiogenic shock Catheter Cardiovasc Interv 75 Suppl 1 2010 S1 S6
146. E. Bates, C. Bode, M. Costa, C.M. Gibson, C. Granger, and C. Green et al. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction Circulation 117 2008 886 896
147. K.W. Mahaffey, C.B. Granger, J.C. Nicolau, W. Ruzyllo, W.D. Weaver, and P. Theroux et al. Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial Circulation 108 2003 1176 1183
148. K. Forster, A. Kuno, N. Solenkova, S.B. Felix, and T. Krieg The delta-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivation Am J Physiol Heart Circ Physiol 293 2007 H1604 H1608
149. 12 blockers confer direct postconditioning-like protection in reperfused rabbit hearts J Cardiovasc Pharmacol Ther 18 2013 251 262
150. V. D'Annunzio, M. Donato, L. Erni, V. Miksztowicz, B. Buchholz, and C.L. Carrion et al. Rosuvastatin given during reperfusion decreases infarct size and inhibits matrix metalloproteinase-2 activity in normocholesterolemic and hypercholesterolemic rabbits J Cardiovasc Pharmacol 53 2009 137 144